Retrospective Clinical Study of COVID-19 Associated With the Condition and Treatment of Patients With Chinese Psoriasis
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 2,500
- 试验地点
- 12
- 主要终点
- The recurrence/exacerbation of psoriasis following SARS-CoV-2 infection
研究概览
简要总结
A retrospective analysis based on database was conducted to evaluate the correlation between covid-19 infection and the condition and treatment of psoriasis patients.
详细描述
Based on the patients registered in the psoriasis patient database of each center, the patients were followed up by telephone, and the severity of covid-19 infection, the change of psoriasis condition and the adjustment of treatment methods of psoriasis patients were collected for retrospective analysis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
The recurrence/exacerbation of psoriasis following SARS-CoV-2 infection
时间窗: March 15,2023 to May 30,2023
The impact of SARS-CoV-2 infection on psoriasis in patients receiving different baseline therapies of psoriasis.
次要结局
- Univariate and multivariate analyses identify risk factors with psoriasis exacerbation/recurrence after SARS-CoV-2 infection(March 15,2023 to May 30,2023)
研究者
Gang Wang, MD
Chief Director of Department of Dermatology
Xijing Hospital